<code id='CB7F5253A6'></code><style id='CB7F5253A6'></style>
    • <acronym id='CB7F5253A6'></acronym>
      <center id='CB7F5253A6'><center id='CB7F5253A6'><tfoot id='CB7F5253A6'></tfoot></center><abbr id='CB7F5253A6'><dir id='CB7F5253A6'><tfoot id='CB7F5253A6'></tfoot><noframes id='CB7F5253A6'>

    • <optgroup id='CB7F5253A6'><strike id='CB7F5253A6'><sup id='CB7F5253A6'></sup></strike><code id='CB7F5253A6'></code></optgroup>
        1. <b id='CB7F5253A6'><label id='CB7F5253A6'><select id='CB7F5253A6'><dt id='CB7F5253A6'><span id='CB7F5253A6'></span></dt></select></label></b><u id='CB7F5253A6'></u>
          <i id='CB7F5253A6'><strike id='CB7F5253A6'><tt id='CB7F5253A6'><pre id='CB7F5253A6'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:entertainment    Page View:15
          Pharmacy shelves
          A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter. GEORGE FREY/AFP via Getty Images

          WASHINGTON — A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter — its highest-ever spend by far, according to federal filings.

          The Council for Citizens Against Government Waste spent $1.1 million on lobbying last quarter, and only employed a single lobbyist. That’s 22 times the $50,000 it spent in the same quarter last year. Its prior spending record was $700,000, from the start of 2020.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more
          Immunocompromised patients offer clues on chronic Covid
          Immunocompromised patients offer clues on chronic Covid

          ThiscolorizedelectronmicroscopeimageshowsSARS-CoV-2,indicatedinyellow,emergingfromthesurfaceofcells,

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

          Wanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyourinb